Abhay Kulkarni

476 total citations
32 papers, 328 citations indexed

About

Abhay Kulkarni is a scholar working on Organic Chemistry, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abhay Kulkarni has authored 32 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abhay Kulkarni's work include Inflammatory mediators and NSAID effects (4 papers), Insect and Pesticide Research (3 papers) and Pesticide Exposure and Toxicity (3 papers). Abhay Kulkarni is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Insect and Pesticide Research (3 papers) and Pesticide Exposure and Toxicity (3 papers). Abhay Kulkarni collaborates with scholars based in India, United States and Australia. Abhay Kulkarni's co-authors include Neelima Khairatkar-Joshi, Indranil Mukhopadhyay, Pravin Kumar, Satish Chandra Pant, R. Vijayaraghavan, Uma Pathak, P. Venkata Rao, K. Ganesan, Nidhi Gupta and Indraneel Ghosh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Abhay Kulkarni

28 papers receiving 312 citations

Peers

Countries citing papers authored by Abhay Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Abhay Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhay Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhay Kulkarni more than expected).

Fields of papers citing papers by Abhay Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhay Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhay Kulkarni. The network helps show where Abhay Kulkarni may publish in the future.

Co-authorship network of co-authors of Abhay Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Abhay Kulkarni. A scholar is included among the top collaborators of Abhay Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhay Kulkarni. Abhay Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Suran L. Fernando, (unknown), (unknown), (unknown), Abhay Kulkarni, Sarah Green	0
2	Scurvy in an Adolescent: A Case Report 2024 ·Cureus ·(unknown), Abhay Kulkarni	3
3	ADOPTING AI-DRIVEN DATA CULTURE IN ORGANIZATION: CHALLENGES AND OPPORTUNITIES FROM EMPLOYEES’ PERSPECTIVES 2024 ·ShodhKosh Journal of Visual and Performing Arts ·Harshal Patil, Abhay Kulkarni	0
4	Serum tryptase changes in children with suspected perioperative hypersensitivity. Comment on BJA Open 2024; 9: 100254 2024 ·SHILAP Revista de lepidopterología ·Stuart A. Green, (unknown), (unknown), Anders Lindberg, Abhay Kulkarni, (unknown)	2
5	An inhibitor of RORγ for chronic pulmonary obstructive disease treatment 2022 ·Scientific Reports ·(unknown), (unknown), (unknown), Prabhakar Tiwari, (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), (unknown), (unknown), (unknown), (unknown), Sachin S. Chaudhari, Sanjib Das, Malini Bajpai, (unknown), Pravin S. Iyer	3
6	The Role of Business Analytics for Enhancing Organizational Performance 2022 ·International Journal of Advanced Research in Science Communication and Technology ·(unknown), Abhay Kulkarni	1
7	A cross sectional study of outcomes of muscle pedicle grafting in neck of femur fractures and avascular necrosis of femoral head 2020 ·Injury ·(unknown), (unknown), Rakesh Patel, Abhay Kulkarni	6
8	Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2 2018 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	5
9	Discovery of 5-(2-chloro-4′-(1H-imidazol-1-yl)-[1,1′-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD 2018 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samitabh Chakraborti, (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	2
10	Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1 2017 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	5
11	Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model 2017 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), Lakshminarayana Narayana, (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	6
12	Treatment of Oral Leukoplakia with Diode Laser: a Pilot Study on Indian Subjects 2016 ·Asian Pacific Journal of Cancer Prevention ·(unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown)	15
13	Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor 2016 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), Abhay Kulkarni, Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	8
14	Transient Receptor Potential Ankyrin 1 Receptor Activation In Vitro and In Vivo by Pro-tussive Agents: GRC 17536 as a Promising Anti-Tussive Therapeutic 2014 ·PLoS ONE ·Indranil Mukhopadhyay, Abhay Kulkarni, (unknown), (unknown), Mahesh Shivarama Shetty, (unknown), Indraneel Ghosh, (unknown), (unknown), Neelima Khairatkar-Joshi	55
15	Pemphigus vulgaris – a report of three cases 2012 ·BMJ Case Reports ·(unknown), Padmanabhan P. Nair, (unknown), Shaji Thomas, Abhay Kulkarni	3
16	Spectrophotometric Investigation of the Charge–Transfer Interaction of 2,3-Dicyano-1,4-naphthoquinone with N-Ethylaniline in Chlorinated Solvents 2012 ·Journal of Solution Chemistry ·(unknown), Gururaj M. Neelgund, Abhay Kulkarni, (unknown)	1
17	Nasal myiasis with orbital and palatal complications 2010 ·BMJ Case Reports ·Shaji Thomas, Padmanabhan P. Nair, (unknown), Abhay Kulkarni	17
18	Differential toxicity of sulfur mustard administered through percutaneous, subcutaneous, and oral routes 2004 ·Toxicology and Applied Pharmacology ·R. Vijayaraghavan, Abhay Kulkarni, Satish Chandra Pant, Pravin Kumar, P. Venkata Rao, Nidhi Gupta, (unknown), K. Ganesan	53
19	Novel S-Substituted Aminoalkylamino Ethanethiols as Potential Antidotes against Sulfur Mustard Toxicity 2004 ·Journal of Medicinal Chemistry ·Uma Pathak, (unknown), Abhay Kulkarni, (unknown), Pravin Kumar, Devendra K. Jaiswal	31
20	Protective Effects of Amifostine and Its Analogues on Sulfur Mustard Toxicity in Vitro and in Vivo 2001 ·Toxicology and Applied Pharmacology ·Rahul Bhattacharya, P.V. Lakshmana Rao, Satish Chandra Pant, (unknown), Rajkumar Tulsawani, Uma Pathak, Abhay Kulkarni, R. Vijayaraghavan	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact